Peter E. Maricondo, a director at Unity Bancorp Inc., has reported several stock transactions that could impact his ownership stake in the company. The transactions, filed on October 22, 2026, involve both the acquisition of shares through stock options and the sale of common stock. This activity is significant as it reflects Maricondo's ongoing involvement with Unity Bancorp and may influence investor perceptions.
Background
Unity Bancorp Inc. is a financial institution incorporated in New Jersey, primarily engaged in the banking sector. It operates under the SIC code for State Commercial Banks. The company trades under the ticker symbol UNTY. Recent filings indicate that Maricondo has been active in reporting his share transactions, which are essential for maintaining transparency with shareholders.
What the Filing Says
According to the recent filing (accession number 0001299077-26-000004), Maricondo reported two significant transactions on October 20, 2026. He acquired 1,600 shares of common stock at a price of $15.70 per share and sold 470 shares at a weighted average price of $56.2459. Following these transactions, Maricondo holds a total of 66,743 shares in Unity Bancorp.
Impact
These transactions may affect shareholders and potential investors by indicating Maricondo's confidence in Unity Bancorp's future. His continued engagement as a director and shareholder reflects a commitment to the company's growth and stability. Investors often pay close attention to insider transactions, as they can provide insights into the company's performance and management's outlook.
What's Next
The filing does not say what happens next regarding Maricondo's future transactions or any potential changes in his role within Unity Bancorp.
Read Next
Naeem Ghauri Acquires 4,000 Shares of Netsol Technologies
CEO Ghauri Najeeb acquires 5,000 shares of NetSol stock
Salmon Tom Reports Acquisition of Shares in Magnera Corp
De Leon Gamboa Naiara acquires 1,860 restricted stock units
PPG Industries' Juliane Hefel Acquires Phantom Stock Units
Sabatini Brent acquires 50,000 RSUs from Vir Biotechnology







